Applied UV, Inc.

Applied UV, Inc.

AUVIQ
Applied UV, Inc.US flagOther OTC
0.00
USD
- -
- -
467.00Market Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
147.75
177.83
124.98
157.27
197.37
- -
177.02
Basic EPS, GAAP
14.08
50.19
-73.45
-107.76
-176.64
- -
-64.44
Free Cash Flow per Basic Share
10.26
14.81
-19.1
-94.72
-85.85
- -
-38.16
Dividend per Share
- -
- -
- -
8.14
14.2
- -
3.35
Book Value per Share
-27.7
22.49
-48.36
-137.65
-276.73
- -
-187.21
Tangible Book Value per Share
-27.7
22.49
208.79
119.69
21.14
- -
-73.21
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
8
9
6
12
20
41
41
Operating Margin (%)
9.97
12.85
-57.79
-62.54
-55.04
-32.16
-32.16
Depreciation Expense
- -
- -
- -
2
3
4
4
Net Income, GAAP
1
3
-3
-7
-17
-13
-13
Effective Tax Rate (%)
- -
4
- -
- -
- -
- -
- -
Profit Margin (%)
9.53
28.22
-58.76
-63.34
-82.3
-32.43
-32.43
Working Capital
1
- -
10
8
1
-11
-11
LT Debt
- -
1
1
1
4
6
6
Total Equity
-1
1
10
33
17
25
25
Return on Invested Capital (%)
- -
339.2
- -
- -
- -
- -
- -
Return on Capital (%)
- -
930.62
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Jun'23
Sep'23
Dec'23
ST Debt
7
7
3
LT Borrowings
5
5
4
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
5
5
5
Shares Outstanding
- -
- -
2
Market Capitalization
3
2
1

Working Capital

FRC

in mil. unless spec.
Jun'23
Sep'23
Dec'23
Total Current Assets
22
21
17
Cash, Cash Equivalents & STI
3
2
1
Accounts Receivable, Net
5
6
4
Inventories
8
8
7
Total Current Liabilities
40
42
28
Payables & Accruals
9
11
9
ST Debt
7
7
3
Deferred Revenue
5
6
6

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
159.78%
44.39%
Free Cash Flow
- -
111.16%
0.19%
Net Income, GAAP
- -
49.69%
-20.34%
Sales/Revenue/Turnover
- -
52.34%
102.18%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
2
2
4
4
12
2022
3
6
6
5
20
2023
11
11
11
8
41

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-14.96
-28.41
-17.54
- -
-107.76
2022
-19.45
-32.08
-151.25
- -
-176.64
2023
-35.38
-19.16
-8.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
3.2
- -
8.14
2022
3.5
3.58
17.89
- -
14.2
2023
2.61
2.3
- -
- -
- -

Company Description

APIChatGPT
CEO
Max Munn
Full Time Employees
131
Sector
Consumer Cyclical
Industry
Furnishings, Fixtures & Appliances
Address
150 North Macquesten Parkway Mount Vernon NY United States of America 10550
IPO Date
Aug 31, 2020
Business
Applied UV, Inc. (NASDAQ: AUVIQ) develops, acquires, markets and sells proprietary surface and air disinfection technologies, indoor air quality products, specialty LED lighting, luxury mirrors and commercial furnishings to healthcare, hospitality, food preservation, cannabis, education, winery, commercial and public venue markets globally. The company offers core products including UVC-based pathogen elimination systems via its Sterilumen subsidiary; innovative UV disinfection solutions such as the Airocide Pro+ for ethylene control and shelf-life extension, Fighter Flex LED and Pulse Modulated UVC LED systems via its Sterilumen and PURO Lighting subsidiaries; lighting and building controls through PURO Lighting, LLC and LED Supply Co., LLC; and custom luxury backlit mirrors, conference room furnishings and case goods through Munn Works, LLC. Founded in 2019 and headquartered in Mount Vernon, New York, Applied UV operates through its wholly owned subsidiaries and maintains strategic manufacturing partnerships including with Canon Virginia, Inc. for produce and floral applications. In recent developments, the company completed mergers with Puro Lighting, LLC and LED Supply Co., LLC in January 2023 to expand its disinfection platform and market reach via relationships with Acuity Brands and distributors like Grainger; launched the patented Fighter Flex LED solution and received provisional patents for advanced UVC systems in early 2024; secured a multi-year exclusive global licensing agreement with Element Designs via a subsidiary in February 2024; closed a $2.76 million registered direct and private placement in March 2024; filed for Chapter 11 bankruptcy protection on May 24, 2024, alongside Sterilumen, Inc., with the case dismissed by the US Bankruptcy Court for the Southern District of New York in June 2025.